Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-200c' Or cancer = '' Total: 63 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-200c bladder cancer down MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
hsa-mir-200c bladder cancer up MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.
hsa-mir-200c bladder cancer down miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
hsa-mir-200c mir-200 bladder cancer down Expression of microRNAs in the Urine of Patients With Bladder Cancer.
hsa-mir-200c mir-200 breast cancer up Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
hsa-mir-200c breast cancer down HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.
hsa-mir-200c breast cancer down miR-200c inhibits breast cancer proliferation by targeting KRAS.
hsa-mir-200c breast cancer down MiR-200c suppresses TGF-? signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
hsa-mir-200c cervical cancer down MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.
hsa-mir-200c cholangiocarcinoma down Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
hsa-mir-200c mir-8 colon cancer down miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c colon cancer up The roles of miR-200c in colon cancer and associated molecular mechanisms.
hsa-mir-200c mir-200 colorectal cancer down MiR-200 suppresses metastases of colorectal cancer through ZEB1.
hsa-mir-200c colorectal cancer down Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
hsa-mir-200c colorectal cancer up Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.
hsa-mir-200c colorectal cancer down miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
hsa-mir-200c colorectal cancer up MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
hsa-mir-200c colorectal cancer up microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
hsa-mir-200c colorectal cancer down Nicotine downregulates microRNA-200c to promote metastasis and the epithelial-mesenchymal transition in human colorectal cancer cells.
hsa-mir-200c colorectal cancer up Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
hsa-mir-200c colorectal cancer down miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer.
hsa-mir-200c endometrial cancer up The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
hsa-mir-200c endometrial cancer down MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
hsa-mir-200c gastric cancer down The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
hsa-mir-200c gastric cancer down MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer.
hsa-mir-200c gastric cancer down miR-200c inhibits TGF-?-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
hsa-mir-200c gastric cancer down miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
hsa-mir-200c glioma down MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration.
hsa-mir-200c glioma down MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.
hsa-mir-200c head and neck squamous cell carcinoma down MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
hsa-mir-200c hepatocellular carcinoma down Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno
hsa-mir-200c hepatocellular carcinoma down Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
hsa-mir-200c kidney cancer down MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells.
hsa-mir-200c laryngeal cancer up MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-200c mir-200 lung adenocarcinoma down miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.
hsa-mir-200c mir-200 lung cancer up MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
hsa-mir-200c mir-200 malignant melanoma up MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
hsa-mir-200c malignant melanoma down Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
hsa-mir-200c malignant melanoma down miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1.
hsa-mir-200c malignant melanoma down miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
hsa-mir-200c mesenchymal cancer down MicroRNA Expression Profiles in Kaposi's Sarcoma.
hsa-mir-200c mucinous cystadenocarcinoma up Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.
hsa-mir-200c nasopharyngeal carcinoma up MicroRNA-200c plays an oncogenic role in nasopharyngeal carcinoma by targeting PTEN.
hsa-mir-200c non-small cell lung cancer up High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
hsa-mir-200c non-small cell lung cancer up Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
hsa-mir-200c non-small cell lung cancer down MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
hsa-mir-200c non-small cell lung cancer down The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.
hsa-mir-200c mir-200 oral cancer down Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.
hsa-mir-200c oral squamous cell carcinoma down MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.
hsa-mir-200c oropharyngeal cancer up MicroRNA profile in site-specific head and neck squamous cell cancer.
hsa-mir-200c ovarian cancer down Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
hsa-mir-200c ovarian cancer up The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.
hsa-mir-200c mir-200 ovarian cancer down A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
hsa-mir-200c ovarian cancer down Long Noncoding RNA MALAT1 Functions as a Sponge of MiR-200c in Ovarian Cancer.
hsa-mir-200c ovarian cancer up miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
hsa-mir-200c ovarian cancer up The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.
hsa-mir-200c ovarian cancer up Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
hsa-mir-200c pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-200c rectal cancer up The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.
hsa-mir-200c renal clear cell carcinoma down Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
hsa-mir-200c renal clear cell carcinoma down miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
hsa-mir-200c-3p gastric cancer down A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients.
hsa-mir-200c-3p pancreatic ductal adenocarcinoma down A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.